AP Biosciences Inc (TPEX:6945)

Revenue by Product

Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2021	Dec 31, 2020
Protein Drugs and Antibody Drugs	32.25M	Log In	Log In
Protein Drugs and Antibody Drugs Growth	361.22%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2021	Dec 31, 2020
China	32.25M	Log In	Log In
China Growth	361.22%	Log In	Log In